VDRM (ViaDerma) EBITDA Margin %: 40.31% (As of Jun. 2012)


What is ViaDerma EBITDA Margin %?

ViaDerma VDRM -25.00% EBITDA Margin % is 40.31% as of Jun. 2012.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. ViaDerma's EBITDA for the three months ended in Jun. 2012 was $2.35 Mil. ViaDerma's Revenue for the three months ended in Jun. 2012 was $5.82 Mil. Therefore, ViaDerma's EBITDA margin for the quarter that ended in Jun. 2012 was 40.31%.

ViaDerma  (OTCPK:VDRM) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

ViaDerma EBITDA Margin % Related Terms

ViaDerma EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for ViaDerma's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ViaDerma EBITDA Margin % Chart

ViaDerma Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
EBITDA Margin %
-777.78 36.75 27.90 34.76 36.07

ViaDerma Quarterly Data
Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.48 31.76 41.26 40.74 40.31

VDRM vs AOLS, RDGL, PCYN: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, ViaDerma's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ViaDerma EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ViaDerma's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where ViaDerma's EBITDA Margin % falls into.


ViaDerma EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

ViaDerma's EBITDA Margin % for the fiscal year that ended in Dec. 2011 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2011 )/Revenue (A: Dec. 2011 )
=6.857/19.008
=36.07 %

ViaDerma's EBITDA Margin % for the quarter that ended in Jun. 2012 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2012 )/Revenue (Q: Jun. 2012 )
=2.345/5.817
=40.31 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 40.31% mean?
ViaDerma (VDRM) has a EBITDA Margin % of 40.31% as of Jun. 2012. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ViaDerma and its competitors.
Is ViaDerma's EBITDA Margin % too high?
ViaDerma's current EBITDA Margin % is 40.31%. The Drug Manufacturers industry median EBITDA Margin % is 12.39. ViaDerma's value of 40.31% is 225.3% above this industry median.
How does ViaDerma's EBITDA Margin % compare to AOLS and RDGL?
ViaDerma's EBITDA Margin % of 40.31% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.39. ViaDerma's value of 40.31% is 225.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.39, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ViaDerma's current EBITDA Margin % of 40.31% is 225.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on ViaDerma and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ViaDerma's current EBITDA Margin % is 40.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ViaDerma stock overvalued right now?
ViaDerma (VDRM) has a current EBITDA Margin % of 40.31%. The current EBITDA Margin % is 40.31% and 225.3% above the Drug Manufacturers industry median of 12.39. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For ViaDerma (VDRM), the current EBITDA Margin % is 40.31% as of Jun. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ViaDerma Business Description

Address 4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292
ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.